Skip to main content
ArticleOPEN ACCESS

Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance

Genome Biology
DOI: 10.1186/s13059-014-0449-4
75Citations
Citations of this article
214Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

DNA fragments released from cancer cells into the blood can be used to generate molecular profiles of tumors. Non-invasive 'liquid biopsies' can be used to monitor minimal residual disease and detect the emergence of drug resistance.

Cite

CITATION STYLE

APA

Siravegna, G., & Bardelli, A. (2014, August 19). Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance. Genome Biology. BioMed Central Ltd. https://doi.org/10.1186/s13059-014-0449-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free